Insider Transactions in Q4 2023 at Lexicon Pharmaceuticals, Inc. (LXRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2023
|
Lonnel Coats Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
90,000
+8.96%
|
$90,000
$1.05 P/Share
|
|
Nov 10
2023
|
Lonnel Coats Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+1.2%
|
$10,000
$1.01 P/Share
|
|
Oct 12
2023
|
Raymond Debbane Director |
BUY
Open market or private purchase
|
Direct |
148,820
+9.99%
|
$148,820
$1.03 P/Share
|
|
Oct 11
2023
|
Raymond Debbane Director |
BUY
Open market or private purchase
|
Direct |
342,874
+22.34%
|
$342,874
$1.08 P/Share
|
|
Oct 10
2023
|
Raymond Debbane Director |
BUY
Open market or private purchase
|
Direct |
508,306
+37.45%
|
$508,306
$1.14 P/Share
|